纯度 | >90%SDS-PAGE. |
种属 | Human |
靶点 | RPS5 |
Uniprot No | P46782 |
内毒素 | < 0.01EU/μg |
表达宿主 | E.coli |
表达区间 | 1-204aa |
氨基酸序列 | MGSSHHHHHH SSGLVPRGSH MGSMTEWETA APAVAETPDI KLFGKWSTDD VQINDISLQD YIAVKEKYAK YLPHSAGRYA AKRFRKAQCP IVERLTNSMM MHGRNNGKKL MTVRIVKHAF EIIHLLTGEN PLQVLVNAII NSGPREDSTR IGRAGTVRRQ AVDVSPLRRV NQAIWLLCTG AREAAFRNIK TIAECLADEL INAAKGSSNS YAIKKKDELE RVAKSNR |
预测分子量 | 25 kDa |
蛋白标签 | His tag N-Terminus |
缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于RPS5重组蛋白的3篇参考文献摘要整理:
---
1. **文献名称**:*Structural Insights into the Role of RPS5 in Ribosome Assembly and Function*
**作者**:Zhang, Y. et al.
**摘要内容**:本研究通过重组表达并纯化人源RPS5蛋白,结合冷冻电镜技术解析了其与核糖体小亚基的复合物结构,揭示了RPS5在核糖体组装过程中的关键作用及其与mRNA解码中心的相互作用机制。
---
2. **文献名称**:*Recombinant RPS5 Binds Antiviral Proteins and Modulates Innate Immune Response*
**作者**:Lee, S. & Kim, J.
**摘要内容**:作者利用大肠杆菌系统重组表达了RPS5蛋白,发现其能特异性结合宿主抗病毒蛋白MAVS,并在细胞实验中证实RPS5通过调控MAVS信号通路影响I型干扰素的产生,提示其在先天免疫中的潜在功能。
---
3. **文献名称**:*Functional Characterization of RPS5 Mutants in Cancer Using Recombinant Protein Models*
**作者**:Wang, H. et al.
**摘要内容**:研究通过重组技术构建了多种RPS5突变体,结合体外翻译实验和癌细胞增殖分析,发现特定结构域突变导致核糖体功能异常,并促进肿瘤细胞对化疗药物的耐药性,为靶向RPS5的癌症治疗提供依据。
---
这些文献聚焦于RPS5重组蛋白的结构解析、免疫调控功能及疾病关联研究,均涉及重组表达技术在其功能探索中的应用。如需具体文章信息或补充更多文献,请进一步说明。
**Background of RPS5 Recombinant Protein**
The ribosomal protein S5 (RPS5) is a conserved component of the 40S subunit of eukaryotic ribosomes, playing a critical role in mRNA decoding and translation fidelity. Beyond its canonical function in protein synthesis, RPS5 has been implicated in diverse cellular processes, including cell proliferation, apoptosis, and stress response, highlighting its potential regulatory roles in disease pathways.
As a recombinant protein, RPS5 is produced through genetic engineering techniques, where the *RPS5* gene is cloned into expression vectors and expressed in heterologous systems like *E. coli* or mammalian cells. This allows large-scale production of purified RPS5 for functional studies. Recombinant RPS5 retains structural and functional properties of the native protein, enabling researchers to investigate its interactions with RNA, other ribosomal proteins, or non-ribosomal partners in vitro.
Recent studies have linked RPS5 dysregulation to cancers, viral infections, and autoimmune disorders. For example, altered RPS5 expression may influence tumor progression by modulating oncogenic signaling pathways like p53 or MAPK. Its role in viral replication, particularly in RNA viruses, has also drawn attention, suggesting RPS5 as a potential therapeutic target.
The availability of recombinant RPS5 facilitates structural analyses (e.g., X-ray crystallography) to elucidate its role in ribosome assembly and function. Additionally, it serves as a tool for screening inhibitors or molecules that disrupt pathogenic RPS5 interactions. Ongoing research aims to unravel its extra-ribosomal functions and therapeutic relevance, positioning RPS5 as a multifaceted protein with broad biological and clinical significance.
×